M. Piqué-Gili

Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma

S. Friedman, J. Llovet, D. Sia, 2021, Hepatology.

Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.

P. Schirmacher, S. Friedman, P. Boffetta, 2021, Journal of hepatology.

Cabozantinib enhances anti-PD1 activity and elicits a neutrophil-based immune response in hepatocellular carcinoma.

V. Mazzaferro, J. Llovet, F. Miró-Mur, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Imaging Calcium in Hippocampal Presynaptic Terminals With a Ratiometric Calcium Sensor in a Novel Transgenic Mouse

N. Hartell, Ibrahim Al-Osta, A. E. Okorocha, 2018, Front. Cell. Neurosci..

Applications of single-cell multi-omics in liver cancer

D. Lambrechts, J. Dekervel, S. Cappuyns, 2024, JHEP reports : innovation in hepatology.